The Department of Dermatology in the Stanford School of Medicine has had a long-standing research-based relationship with Nu Skin Enterprises.

FORBES: Preying on an Easy Mark

Researchers in the department currently have one on-going study funded by Nu Skin related to the identification of master regulators and epigenetic changes to human skin aging.

FORBES: Preying on an Easy Mark

However, another company called Pharmanex , a subsidiary of Nu Skin Enterprises nus (nyse: nus - news - people), peddles the same compound under the brand name Cholestin.

FORBES: FDA Rejects Over-The-Counter Cholesterol Drugs